RCUS
Price
$8.18
Change
-$0.29 (-3.42%)
Updated
Jul 7, 12:41 PM (EDT)
Capitalization
896.85M
24 days until earnings call
VERU
Price
$0.59
Change
-$0.02 (-3.28%)
Updated
Jul 7, 02:48 PM (EDT)
Capitalization
88.92M
31 days until earnings call
Interact to see
Advertisement

RCUS vs VERU

Header iconRCUS vs VERU Comparison
Open Charts RCUS vs VERUBanner chart's image
Arcus Biosciences
Price$8.18
Change-$0.29 (-3.42%)
Volume$100
Capitalization896.85M
Veru
Price$0.59
Change-$0.02 (-3.28%)
Volume$200
Capitalization88.92M
RCUS vs VERU Comparison Chart in %
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. VERU commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and VERU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (RCUS: $8.47 vs. VERU: $0.61)
Brand notoriety: RCUS and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 26% vs. VERU: 30%
Market capitalization -- RCUS: $896.85M vs. VERU: $88.92M
RCUS [@Biotechnology] is valued at $896.85M. VERU’s [@Biotechnology] market capitalization is $88.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 2 TA indicator(s) are bullish while VERU’s TA Score has 6 bullish TA indicator(s).

  • RCUS’s TA Score: 2 bullish, 7 bearish.
  • VERU’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VERU is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а -0.35% price change this week, while VERU (@Biotechnology) price change was -7.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

VERU is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($897M) has a higher market cap than VERU($88.9M). VERU YTD gains are higher at: -6.749 vs. RCUS (-43.116). VERU has higher annual earnings (EBITDA): -39.09M vs. RCUS (-377M). RCUS has more cash in the bank: 997M vs. VERU (20M). VERU has less debt than RCUS: VERU (3.39M) vs RCUS (60M). RCUS has higher revenues than VERU: RCUS (141M) vs VERU (16.9M).
RCUSVERURCUS / VERU
Capitalization897M88.9M1,009%
EBITDA-377M-39.09M965%
Gain YTD-43.116-6.749639%
P/E RatioN/AN/A-
Revenue141M16.9M834%
Total Cash997M20M4,985%
Total Debt60M3.39M1,770%
FUNDAMENTALS RATINGS
RCUS vs VERU: Fundamental Ratings
RCUS
VERU
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6463
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCUS's Valuation (52) in the Pharmaceuticals Major industry is somewhat better than the same rating for VERU (100) in the Household Or Personal Care industry. This means that RCUS’s stock grew somewhat faster than VERU’s over the last 12 months.

RCUS's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that RCUS’s stock grew similarly to VERU’s over the last 12 months.

RCUS's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as VERU (98) in the Household Or Personal Care industry. This means that RCUS’s stock grew similarly to VERU’s over the last 12 months.

VERU's Price Growth Rating (63) in the Household Or Personal Care industry is in the same range as RCUS (64) in the Pharmaceuticals Major industry. This means that VERU’s stock grew similarly to RCUS’s over the last 12 months.

RCUS's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that RCUS’s stock grew similarly to VERU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCUSVERU
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
85%
Momentum
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
81%
MACD
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 5 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAEPY6.340.46
+7.82%
Kansai Electric Power Co., Inc. (The)
APMRF0.16N/A
N/A
Amper SA Madrid
SBFFY26.98N/A
N/A
SBM Offshore NV
SBNYL3.75-0.05
-1.32%
Signature Bank (New York, NY)
SCIA4.08-0.27
-6.21%
SCI Engineered Materials, Inc.

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-1.40%
XNCR - RCUS
49%
Loosely correlated
+1.45%
TRDA - RCUS
48%
Loosely correlated
N/A
IMNM - RCUS
47%
Loosely correlated
+2.43%
APGE - RCUS
47%
Loosely correlated
+7.08%
ACLX - RCUS
47%
Loosely correlated
+1.24%
More

VERU and

Correlation & Price change

A.I.dvisor tells us that VERU and COGT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VERU and COGT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+3.94%
COGT - VERU
32%
Poorly correlated
+2.29%
BMEA - VERU
31%
Poorly correlated
-3.49%
RCUS - VERU
30%
Poorly correlated
-1.40%
HOFBF - VERU
29%
Poorly correlated
N/A
SRRK - VERU
28%
Poorly correlated
+1.24%
More